~~<i id='3B6F3DCF36'><strike id='3B6F3DCF36'><tt id='3B6F3DCF36'><pre id='3B6F3DCF36'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

entertainment

author：entertainment 2025-10-01 02:14:01 - browse：61542

Acadia Pharmaceuticals said Monday that its approved medicine called Nuplazid failed to improve the social and emotional symptoms of schizophrenia in a late-stage clinical trial.

The negative outcome of the Phase 3 study represents a setback in the company’s efforts to expand the use of Nuplazid into the treatment of schizophrenia. The medicine is currently approved to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

“We are disappointed the trial did not meet its primary endpoint given the significant unmet need in patients with negative symptoms of schizophrenia,” said Acadia CEO Steve Davis, in a statement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Adele warns fans about throwing things at performers onstage

focus

leisure time

explore

knowledge

explore

focus

1:04AframefromvideoreleasedbytheU.S.thatofficialssaidshowsdronesinSyriabeingharassedbyRussianjetsonW

WSS

The leaders of Italy and Poland say European Union should focus on stopping migration

Will the IRA bring competition to the biologics market?

Acelyrin, a rare IPO success, stumbles in its first big test

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Wikipedia

entertainment

focus

As demand for Covid shots wanes, Moderna seeks its next success

Former New York Mayor de Blasio and wife announce separation, but not divorce

Trump demands the U.S. pay no more for drugs than other countries … again

How medical schools plan to diversify without affirmative action

After affirmative action ruling, medical educators look to 'holistic review'

Pentagon will tighten controls on classified information after Discord leak

Guidelines to prevent youth baseball injuries need more muscle

Diverse clinical trials: Why aren’t we there yet?

Medical records are filled with copy

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

leisure time

How medical schools plan to diversify without affirmative action

Hospitals consider fixing cancer drug shortages on their own

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Food makers tried to stack nutrition panel with preferred experts

Telehealth for opioid use disorder is lifesaving

explore

knowledge

explore

focus